Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday
Portfolio Pulse from Avi Kapoor
Several key stocks are expected to grab investor focus today, including Bank of America, Morgan Stanley, FB Financial, Kyverna Therapeutics, and UnitedHealth Group. Bank of America and Morgan Stanley are set to release their earnings reports, while Kyverna Therapeutics received FDA designation for a new treatment.
July 16, 2024 | 7:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bank of America is expected to report quarterly earnings of 80 cents per share on revenue of $25.22 billion. Shares gained 0.1% in after-hours trading.
Positive earnings expectations and slight after-hours gain suggest a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
FB Financial posted better-than-expected Q2 results, with shares rising 0.5% in after-hours trading.
Better-than-expected results and after-hours gain indicate positive short-term impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Kyverna Therapeutics received FDA Regenerative Medicine Advanced Therapy designation for KYV-101, leading to a 7.5% surge in after-hours trading.
FDA designation is a significant milestone, leading to a substantial after-hours price increase.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Morgan Stanley is expected to report quarterly earnings of $1.65 per share on revenue of $14.3 billion. Shares rose 0.8% in after-hours trading.
Positive earnings expectations and after-hours gain suggest a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
UnitedHealth Group is expected to report quarterly earnings of $6.66 per share on revenue of $98.84 billion. Shares rose 0.9% in after-hours trading.
Positive earnings expectations and after-hours gain suggest a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100